Company Filing History:
2 out of 223 
2 out of 489 
1 out of 366 
Years Active: 2007-2016
Title: Innovations of Nico Lm Callewaert
Introduction
Nico Lm Callewaert is a notable inventor based in Lichtervelde, Belgium. He has made significant contributions to the field of biotechnology, particularly in the area of protein glycosylation and liver fibrosis diagnostics. With a total of two patents to his name, Callewaert's work has the potential to impact both medical and industrial applications.
Latest Patents
Callewaert's latest patents include "Protein glycosylation modification in methylotrophic yeast." This invention provides genetically engineered strains capable of producing proteins with reduced glycosylation. The genetically engineered strains can express either or both of an α-1,2-mannosidase and glucosidase II. Furthermore, these strains can be modified to disrupt the OCH1 gene, allowing for methods of producing glycoproteins with reduced glycosylation. Another significant patent is "Serum marker for measuring liver fibrosis." This invention offers methods and kits to detect liver fibrosis or changes in its gradation in mammals. The diagnostic marker is based on profiling and identifying diagnostic carbohydrates present in body fluids such as blood serum.
Career Highlights
Throughout his career, Callewaert has worked with various organizations, including Vib Vzw and Universiteit Gent. His experience in these institutions has contributed to his expertise in biotechnology and innovation.
Collaborations
Callewaert has collaborated with notable individuals such as Roland Henri Contreras and Steven Cj Geysens. These collaborations have likely enriched his research and development efforts.
Conclusion
Nico Lm Callewaert is a distinguished inventor whose work in protein glycosylation and liver fibrosis diagnostics showcases his innovative spirit. His contributions to biotechnology are noteworthy and have the potential to lead to significant advancements in the field.